ࡱ> 574 bjbjVV 4<<  //// ;/!>WWWWW222B!D!D!D!D!D!D!#&BD!22D!WWY!www.WWB!wB!ww:*,W`m/M V .!o!0!`.&W&&2"Twl222D!D!g222!&222222222 : MEDICAL BIOTECHNOLOGY (WITH BIO-BUSINESS) (MSc/PgDip/PgCert) 57C560B1/61C5MBVX/62C5MBVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard, in a relevant biological subject or other relevant discipline. Duration: 12 months full-time or 24 months part time (MSc); 9 months full-time (PgDip) Content: This course has been specifically designed to recognise the commercial maturating of medical biotechnology in Europe and the US, whilst at the same time acknowledging the rapid growth in biotechnological science in many other parts of the world. The course provides a fusion of modules covering many of the latest scientific developments in drug discovery, therapeutics and disease prevention, together with an introduction to the commercial, legal (intellectual property) and ethical aspects of todays bio-business world. This postgraduate course will provide a unique opportunity to gain experience of the latest science and business developments in the fast moving world of medical biotechnology. For the students embarking on this course, significant emphasis will be placed on self-directed learning allied to a tutorial programme. Candidates shall be required to attend the following designated courses: Stage 1 BT 5009 Immunology: Back to Basics (0 credit points) BT 5010 Small Molecular Drug Discovery (25 credit points) BT 5011 Introduction to Bio-Business and the Commercialisation of Bioscience Research (10 credit points) MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) MB 5016 Advanced Molecular and Functional Genomics (15 credit points) GS 50M1 Generic Skills Module (0 credit points) SK 5003 Information Skills (0 credit points) Stage 2 BT 5502 Special study module 2: Biologics (focus on large molecular weight molecules such as peptides and proteins) the next generation of therapeutic agents (25 credit points) BT 5901 Laboratory Techniques core practical skills (10 credit points) BT 5508 Advanced Bio-Business and Commercialisation of Bioscience Research (15 credit points) Elective BT 5506 Business of Science (5 credit points) MT 55EP Careers & Employability for Postgraduates (5 credit points) Stage 3 BT 5703 Research Project (60 credit points) [MSc candidates] BT 5704 Extended Essay (Subject area will be governed by research project) (10 credit points) In addition to lectures, the above courses will include practical training in gene cloning and computer modelling, assessed presentations and three major essay assignments. Throughout the programme, students will be given further instruction in aspects of laboratory safety and will attend sessions to improve their computing skills. The course will also include contributions from leading scientific academics and tutorials from senior members of the UK bio-business community. The students will also be given the opportunity to attend employability classes and careers workshops. Assessment: By course work, by written examinations, or by a combination of these, as prescribed for each course. All candidates shall attend an oral examination, and MSc candidates shall be required to submit a thesis on their project. The degree of MSc shall not be awarded to a candidate who fails to achieve a CAS mark of 9 or above in BT 5702S, irrespective of their performance in other courses: such candidates may be awarded a Postgraduate Diploma if they have achieved the appropriate number of credits for that award. YrO W ٸٟ٘ hAjhCJhlMhlM6OJQJaJhlM>*OJQJaJhlMhlM>*OJQJaJ%hlMhlM56>*CJOJQJaJhlMhlMOJQJaJhlM>*OJQJhlM6OJQJhlMOJQJXYN O   + f W 0gdlM gdlM d6gdlM 0d6gdlM$ 0D%d6a$gdlMo N78 *gdlM  9r gdlM gdlM |^`|gdlM 0gdlM 0gdlMgdAj21h:p[=. A!"#$% j 666666666vvvvvvvvv66666>66666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH N`N  Normal$a$ CJOJPJQJ_HmH sH tH `@` + Heading 2$<@&$56CJOJPJQJ\]^JaJ>@>   Heading 3$d8@&5XX = Heading 6 <@&5CJOJPJQJ\^JaJRR "2^ Heading 7 <@&CJOJPJQJ^JaJXX N$ Heading 8 <@&6CJOJPJQJ]^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List PP  Heading 3 Char5CJOJPJQJ^JaJ\\ +Heading 2 Char(56CJOJPJQJ\]^JaJtH 4@4 +Header  9r B!B + Header CharCJOJPJQJtH V1V =Heading 6 Char"5CJOJPJQJ\^JaJtH PAP "2^Heading 7 CharCJOJPJQJ^JaJtH JZRJ w0 Plain Text$a$CJOJQJ^JtH FaF w0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ 0d6a$ 5OJQJPP ftBody Text 3 Char5CJOJPJQJtH VV N$Heading 8 Char"6CJOJPJQJ]^JaJtH 6U6 mO Hyperlink >*B*phPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]   8@0(  B S  ?s  s   B*urn:schemas-microsoft-com:office:smarttagscountry-region9 *urn:schemas-microsoft-com:office:smarttagsplace  /45;GL    zp>}z<<^<`o(.^`o(()zLz^z`L.J J ^J `.  ^ `.L^`L.^`.^`.ZLZ^Z`L. ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(}zzp         b_ BkwgH J&d =gu(,v[!)"Z%l.3g8x;[=Q@B|BsICJqKLyLlMw}MmOgNPk,Q_WEuW^]"2^H_a;aMVataEcFe%'gQ=gy&jDzj\Al9o(tftvYxH y%z7g|4&}?7}Aj.sl a=w ~(u.t9aj +M7R.~N$h-mO|5$mg;Sdz9B}%R9g @ @Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.{ @CalibriY CG TimesTimes New Roman7K@Cambria?= *Cx Courier New;WingdingsA BCambria Math"qh=f=f  !r0 3HP $P 2!xxRobertRobert  Oh+'0 px  RobertNormalRobert2Microsoft Office Word@@m@m ՜.+,0 hp|     Title  !"#%&'()*+-./01236Root Entry F*cm81Table&WordDocument4SummaryInformation($DocumentSummaryInformation8,CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q